N-PORT filing recap · October 2019

What did Polen Growth Fund buy in October 2019?

Reported stock-position changes between this filing and the previous one. These are Polen Growth Fund's own holdings, not the firm's.

Stock value

$4.34B

Positions

Estimated turnover

—

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

MSFTMicrosoft Corporation$431.09Mreported value+3.01M shares METAMeta Platforms, Inc.$353.50Mreported value+1.84M shares VVisa Inc.$325.76Mreported value+1.82M shares GOOGAlphabet Inc.$312.00Mreported value+247.6K shares ZTSZoetis Inc.$252.16Mreported value+1.97M shares ADBEAdobe Inc.$245.18Mreported value+882.2K shares MAMastercard Inc$235.82Mreported value+851.9K shares ACNAccenture Plc$203.65Mreported value+1.10M shares DGDollar General Corp$189.53Mreported value+1.18M shares ORLYO Reilly Automotive Inc$181.22Mreported value+416.1K shares NKENike, Inc.$174.34Mreported value+1.95M shares NSRGYNestle SA$152.69Mreported value+1.42M shares ORCLOracle Corporation$150.88Mreported value+2.77M shares ITGartner, Inc.$147.57Mreported value+957.8K shares PYPLPayPal Holdings, Inc.$145.19Mreported value+1.39M shares ADPAutomatic Data Processing Inc$145.00Mreported value+893.8K shares ALGNAlign Technology, Inc.$123.44Mreported value+489.3K shares SBUXStarbucks Corporation$111.75Mreported value+1.32M shares GOOGLAlphabet Inc.$98.06Mreported value+77.9K shares REGNRegeneron Pharmaceuticals, Inc.$94.69Mreported value+309.2K shares MSCIMsci Inc.$91.34Mreported value+389.4K shares BKNGBooking Holdings Inc.$90.47Mreported value+44.2K shares CRMSalesforce, Inc.$85.80Mreported value+548.3K shares